课题基金 / 基金详情

IGF::OT::IGF COMPACT, LOW-COST, HIGH-INTENSITY SUPERCONDUCTING ISOCHRONOUS CYCLO

IGF::OT::IGF COMPACT, LOW-COST, HIGH-INTENSITY SUPERCONDUCTING ISOCHRONOUS CYCLO
IGF::OT::IGF 紧凑型、低成本、高强度超导等时循环
批准号:
8744542
负责人:
TIMOTHY A. ANTAYA
金额:
$20.38万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-25 至 2014-06-24

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
与传统的X射线放射治疗相比,质子束放射治疗(PBRT)能够提供 高度精确的辐射剂量的癌细胞,从而导致更少的短期和长期的副作用 方面的影响.尽管PBRT具有优势,但由于成本和复杂性,其广泛采用受到限制。 技术。质子的全部优点只能通过称为spot的先进射束输送来获得 射束扫描(SBS),其中可变剂量被递送到个体体素。SBS所需的光束 不能从任何现存的促进剂中成本有效地获得。 安塔亚科技超导等离子体回旋加速器, 体积小、重量轻、价格低、简单性和可靠性高的解决方案。安泰亚科技 技术预计,它可以将回旋加速器组件的成本降低约50%,并帮助 使质子治疗的成本不超过X射线治疗,对许多癌症有非常显着的好处 患者
英文摘要
Compared with conventional X-ray radiation therapy, proton beam radiation therapy (PBRT) is able to deliver a highly precise dose of radiation to the cancer cells, which results in fewer short-term and long-term side effects. Despite its advantages, PBRT has been limited in its wider adoption due to the cost and complexity of the technology. The full advantage of protons can only be obtained by advanced beam delivery called spot beam scanning (SBS), wherein a variable dose is delivered to individual voxels. The beam required for SBS cannot be obtained cost effectively from any of the extant accelerators. The Antaya Science & Technology Superconducting Isochronous Cyclotron proposed here with its smaller size, lighter weight, lower price and greater simplicity and reliability provides a solution. Antaya Science & Technology expects that it can reduce the cost of the cyclotron component by approximately 50% and help enable proton therapy to cost no more than X-ray therapy with very significant benefits to many cancer patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金